Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs MINISO Group Holding Ltd — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while MINISO Group Holding Ltd trades at $10.42 (market cap $3.05B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.9× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays a 6.52% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and MINISO Group Holding Ltd for 25 Days on average.
| KYMR | MNSO | |
|---|---|---|
Market Cap | $8.88B | $3.05B |
Volume | 1,028,790 | 2,038,133 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $22.75 |
52-Week Low | $55.80 | $8.60 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $8.27B | $3.92B |
Dividend Yield | — | 6.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MNSO trades at $9.92, up 1.95% today. The stock shows mixed earnings with a recent beat in Q1 2026 but misses in other quarters. Revenue grew to $21.44 billion in 2025, with a net income margin of 5.35%. Technical indicators are bullish overall, with the price near key support at $10. Analyst sentiment is positive with a 60% buy rating.
The outlook is cautiously optimistic given solid revenue growth and reasonable valuation (P/E 16.6), but earnings volatility and competitive pressures pose risks. Upside depends on sustained operational improvements and margin expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
